About Nimble Therapeutics
Nimble Therapeutics is a company based in Madison (United States) founded in 2019 was acquired by AbbVie in December 2024.. Nimble Therapeutics has raised $10 million across 1 funding round from investors including AbbVie and Telegraph Hill Partners. The company has 24 employees as of December 31, 2021. Nimble Therapeutics operates in a competitive market with competitors including Aqemia, NTxBio, Applied BioMath, Enveda and IMIDomics, among others.
- Headquarter Madison, United States
- Employees 24 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nimble Therapeutics, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Nimble Therapeutics
Nimble Therapeutics has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $10.0M
-
First Round
First Round
(30 Apr 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2019 | Amount | Series A - Nimble Therapeutics | Valuation | Telegraph Hill Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nimble Therapeutics
Nimble Therapeutics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include AbbVie and Telegraph Hill Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Founded Year | Domain | Location | |
|
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nimble Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nimble Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nimble Therapeutics Comparisons
Competitors of Nimble Therapeutics
Nimble Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aqemia, NTxBio, Applied BioMath, Enveda and IMIDomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic molecules are discovered through AI and quantum physics integration.
|
|
| domain | founded_year | HQ Location |
Provider of bio informatics platform to develops biologics and therapeutics
|
|
| domain | founded_year | HQ Location |
Systems biology and pharmacology modeling services to aid drug discovery and development
|
|
| domain | founded_year | HQ Location |
Provider of AI-based platform to decipher the chemistry of nature and develop new medicines
|
|
| domain | founded_year | HQ Location |
Precision medicines for immune-mediated inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nimble Therapeutics
Frequently Asked Questions about Nimble Therapeutics
When was Nimble Therapeutics founded?
Nimble Therapeutics was founded in 2019.
Where is Nimble Therapeutics located?
Nimble Therapeutics is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Is Nimble Therapeutics a funded company?
Nimble Therapeutics is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Apr 30, 2019.
How many employees does Nimble Therapeutics have?
As of Dec 31, 2021, the latest employee count at Nimble Therapeutics is 24.
What does Nimble Therapeutics do?
Nimble Therapeutics was founded in 2019 in Madison, United States, within the biotechnology sector. Drug discovery services centered on combinatorial chemistry are offered, with a focus on peptide technologies. A chemical synthesis platform has been developed to facilitate the creation and evaluation of various peptides, including scaffolded natural and modified macrocyclic peptidomimetics. Operations emphasize efficient screening processes for potential therapeutic compounds in the pharmaceutical industry.
Who are the top competitors of Nimble Therapeutics?
Who are Nimble Therapeutics's investors?
Nimble Therapeutics has 2 investors. Key investors include AbbVie, and Telegraph Hill Partners.